Boston Sci Recalls Some Lotus Valves After 3 Deaths
Executive Summary
The company is recalling unused valves made before March 2016, which use a component that may break during deployment. Three patients have died of hemorrhage caused by the breakage.
You may also be interested in...
Boston Scientific’s Lotus TAVR Gets Boost From REPRISE II And UK Series
Boston Scientific’s Lotus transcatheter aortic valve replacement system demonstrated favorable outcomes in the REPRISE II trial and a 228-case series in the UK.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.
Interview: Theradaptive To Enter Clinical Trial For Spinal Fusion Implant
Theradaptive, which makes a device-biologic combination product to help speed bone healing, recently got authorization to start human trials from the US FDA. Medtech Insight spoke to CEO Luis Alvarez about the company’s past, present and future.